VEGFA and proliferative diabetic retinopathy: In addition, while an exogenous VEGF injection was used to mimic increased endogenous VEGF levels, the dose of 500 ng per eye used in the current study is higher than that usually found in age-related macular degeneration or proliferative diabetic retinopathy [50], [51].